PGR and neoplasm: Ninety-four (64%) patients had a G3 tumor, proliferation index was elevated (i.e. Ki67 ≥ 20%) in 99 (67%) patients, estrogen and progesterone receptors were ≥ 10% positive in 92 (62%) and 66 (45%) patients, respectively.